USPTO serial 79121813
ZINCOVER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 15, 2013
- Examiner
- ORNDORFF, LINDA
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ZINCOVER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
BERKO ILAÇ VE KIMYA SANAYI ANONIM SIRKETI
Y.Dudullu-Umraniye-Istanbul, TR
Other trademarks owned by BERKO ILAÇ VE KIMYA SANAYI ANONIM SIRKETI
BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI
Istanbul, TR
Other trademarks owned by BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI
BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI
TR
Other trademarks owned by BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Wayne V. Harper
2112 W. Marjory AvenueTampa, FL 33606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Soaps for body, soaps for household purposes, soaps for personal use, shampoos for personal use, all or in part containing zinc | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceuticals for human health for the treatment of anemia and assisting energy metabolism; systemic anti-infectives, namely, antibacterial and antifungal pharmaceuticals; musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; cardiovascular pharmaceuticals, namely, diuretics, lipid lowering agents, beta blocking agents, calcium antagonists and other cardiovascular products; pharmaceuticals for the prevention and treatment of disorders of the nervous system, namely, analgesics, psychoanaleptics, psycoleptics, anti-epileptics, central nervous system drugs, anaesthetics, anti-Parkinson preparations; pharmaceuticals for the treatment of respiratory diseases and asthma; dermatological pharmaceutical products; pharmaceuticals for the treatment of hormonal disorders and the prevention of osteoporosis; anti-diabetic pharmaceuticals; pharmaceuticals for the treatment of bone diseases and joint diseases; pharmaceuticals for the treatment of viral and infectious diseases; pharmaceuticals for use as antineoplastic agents; pharmaceuticals for the treatment of immune system related diseases and disorders; pharmaceuticals for the treatment of kidney diseases; pharmaceuticals for ophthalmological use; chemical preparations for medical purposes, namely, vitamin and mineral supplements to support the growth of children, vitamins and dietary supplements to support arousing the appetite, all or in part containing zinc | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BERKO ILAÇ VE KIMYA SANAYI ANONIM SIRKETI
- Other trademarks owned by BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI
- Other trademarks owned by BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named ZINCOVER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 15, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 4, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 3, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 3, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 27, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 26, 2024 | C71T | CANCELLED SECTION 71 | — |
| Oct 15, 2022 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| May 13, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 22, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 10, 2020 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 10, 2020 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 10, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 15, 2020 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Apr 14, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 14, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 14, 2020 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Apr 14, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 14, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 14, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 15, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 15, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 3, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 8, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 16, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 2, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 16, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 16, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 15, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 15, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 5, 2013 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 30, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 30, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 10, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 27, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 26, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 25, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 25, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jun 20, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 14, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 22, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 21, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 20, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 20, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 19, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 18, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 13, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |